NIDA Notes keeps you up to date on research advances in the causes, consequences, prevention, and treatment of drug abuse and addiction and HIV/AIDS.
Learn more about NIDA Notes
Describes a new research finding indicating that the antidepressant sertraline (Zoloft), prescribed to relieve depression during the methamphetamine withdrawal process, may make quitting harder.
Discusses the role of epigenetics, the study of cellular mechanisms that control gene expression and its impacts on health and behavior, in addiction research.
Describes a study investigating the use of the antidepressant bupropion as a potential therapy for methamphetamine addiction.
Reviews a journal supplement that compiles studies on drug-related HIV transmission, with a focus on injection drug use, in 16 different localities across the globe.
Reports on two studies indicating that orexin, a neuropeptide that stimulates eating and regulates wakefulness, also fosters animals' drug seeking and craving responses to drugs.
Reports data on the prevalence of substance use among college students with ADHD, comparing those who received ADHD treatment with those who did not.
Describes research investigating a naturally occurring brain chemical that shows early promise as a treatment for addiction in animal studies.
Describes the role of the Division of Clinical Neuroscience and Behavioral Research in NIDA’s drug abuse and addiction research plan.
Presents highlights of a study indicating that exposure to morphine during adolescence may increase sensitivity to the drug during adulthood.
NIDA @ Work: Dr. David Thomas